Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Subodh Verma, MD, PhD
Tirzepatide reduces HF events in patients with HFpEF and obesity
Milton Packer, MD
How Artificial Sweeteners Could Be Linked to Heart Disease
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Wilson Tang, MD
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Javed Butler
Chiadi Ndumele, M.D., Ph.D., M.H.S.
A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults
Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
What the SODIUM-HF Trial Means for Heart Failure Patients
Justin Ezekowitz, MD, MBBCh, MSc
Novel Form of CV Research with Dietary Education in the Grocery Store
Challenging the Theory That Light Alcohol Consumption Benefits Heart Health
What to Know About the No Surprises Act
Charles Turck, PharmD, BCPS, BCCCP
Emily Carroll, JD, MSW
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.